NCT05504902
Vibrotactile Coordinated Reset for the Treatment of Advanced Parkinson's Disease
Enrolling by Invitation
NAAges 18+InterventionalTreatmentStanford UniversityInvestigator-initiated
~35 participants
Updated 2024-08-19 on ClinicalTrials.gov
What's tested:Vibrotactile coordinated reset
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3 (MDS-UPDRS III) off medication
Measured over Baseline, 6 months, 12 months, 18 months, 24 months
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3 (MDS-UPDRS III) off medicationBaseline, 6 months, 12 months, 18 months, 24 months
This scale measures motor ability within Parkinson's patients. For part 3, the scales minimum values is 0 and max value is 132. Higher scores indicate more impaired motor ability, while lower scores indicate less impaired motor ability. A score of 0 indicates no motor impairment. This assessment is performed while participants are off Parkinson's-related medication.